Literature DB >> 10986530

Stenotrophomonas maltophilia endocarditis of prosthetic aortic valve: report of a case and review of literature.

N J Mehta1, I A Khan, R N Mehta, A Gulati.   

Abstract

Stenotrophomonas Maltophilia (previously known as Xanthomonas maltophilia and Pseudomonas maltophilia ) is an aerobic, nonfermenting, gram-negative bacillus, which has emerged as a serious nosocomial pathogen in patients with compromised immunity. It is a rare cause of endocarditis with only 20 cases previously reported in medical literature. The risk factors associated with S maltophilia endocarditis include intravenous drug abuse, dental treatment, previous cardiac surgery, and infected intravascular devices. S maltophilia is resistant to multiple antibiotics, which leads to frequent therapeutic failures. Although the optimal antibiotic treatment for S maltophilia endocarditis remains unknown, most of the patients received 2 or more antibiotics. We report a case of S maltophilia endocarditis of prosthetic aortic valve, associated with a painless aortic dissection, that responded well to a combination of ciprofloxacin and chloramphenicol. The literature is reviewed to elaborate the disease characteristics, the treatments used, and the prognosis of the S maltophilia endocarditis.

Entities:  

Mesh:

Year:  2000        PMID: 10986530     DOI: 10.1067/mhl.2000.108362

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  2 in total

1.  Cluster of Stenotrophomonas maltophilia endocarditis after prosthetic valve replacement.

Authors:  Manica Müller-Premru; Tone Gabrijelcic; Borut Gersak; Jana Kolman; Natasa Svent-Kucina; Vesna Spik; Tatjana Lejko-Zupanc
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 2.  A new strategy to fight antimicrobial resistance: the revival of old antibiotics.

Authors:  Nadim Cassir; Jean-Marc Rolain; Philippe Brouqui
Journal:  Front Microbiol       Date:  2014-10-20       Impact factor: 5.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.